Swiss Rockets Partners with Squirro to Transform AI in Biotech
Basel, Switzerland – October 23, 2025: Swiss Rockets AG has announced a strategic partnership with Squirro AG aimed at...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Basel, Switzerland – October 23, 2025: Swiss Rockets AG has announced a strategic partnership with Squirro AG aimed at...
BRIDGEWATER, N.J., and BENGALURU, India – October 16, 2025: Biocon Biologics Ltd., a global leader in biosimilars, has expanded...
October 14, 2025 | Dallas, TX & Aurora, CO — Verily, UCHealth, the University of Colorado Anschutz, and RefinedScience...
LONDON, Oct. 8, 2025 — Haleon, the world’s largest pure-play consumer health company, has partnered with Salesforce to deploy...
SEOUL, South Korea — September 22, 2025 — Lunit and Agilent Technologies have launched a non-exclusive collaboration to co-develop...
September 15, 2025 — Taipei, Taiwan Glac Biotech, a Taiwan-based developer of probiotics and postbiotics, announced that its core...
